About DelMar Pharmaceuticals
DelMar Pharmaceuticals is a company based in Vancouver (Canada) founded in 2010.. DelMar Pharmaceuticals has raised $7.9 million across 10 funding rounds from investors including National Research Council Canada. The company has 3 employees as of June 30, 2022. DelMar Pharmaceuticals has completed 1 acquisition, including Adgero Biopharma. DelMar Pharmaceuticals operates in a competitive market with competitors including Jazz Pharmaceuticals, Insitro, BridgeBio, ATAI and C4 Therapeutics, among others.
- Headquarter Vancouver, Canada
- Employees 3 as on 30 Jun, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Delmar Pharmaceuticals, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$7.9 M (USD)
in 10 rounds
-
Latest Funding Round
- Investors
-
Employee Count
3
as on Jun 30, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of DelMar Pharmaceuticals
DelMar Pharmaceuticals has successfully raised a total of $7.9M across 10 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Last Round
-
First Round
First Round
(25 Jan 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Post-IPO - DelMar Pharmaceuticals | Valuation |
investors |
|
| Jan, 2017 | Amount | Grant - DelMar Pharmaceuticals | Valuation |
investors |
|
| May, 2016 | Amount | Post-IPO - DelMar Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DelMar Pharmaceuticals
DelMar Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Research Council Canada. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Scientific and technological research is conducted for Canada's benefit.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DelMar Pharmaceuticals
DelMar Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Adgero Biopharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Photodynamic therapy for cutaneous metastatic breast cancer is developed.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - DelMar Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Delmar Pharmaceuticals Comparisons
Competitors of DelMar Pharmaceuticals
DelMar Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Insitro, BridgeBio, ATAI and C4 Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Delmar Pharmaceuticals
Frequently Asked Questions about DelMar Pharmaceuticals
When was DelMar Pharmaceuticals founded?
DelMar Pharmaceuticals was founded in 2010 and raised its 1st funding round 3 years after it was founded.
Where is DelMar Pharmaceuticals located?
DelMar Pharmaceuticals is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Is DelMar Pharmaceuticals a funded company?
DelMar Pharmaceuticals is a funded company, having raised a total of $7.9M across 10 funding rounds to date. The company's 1st funding round was a Post-IPO of $5.6M, raised on Jan 25, 2013.
How many employees does DelMar Pharmaceuticals have?
As of Jun 30, 2022, the latest employee count at DelMar Pharmaceuticals is 3.
What does DelMar Pharmaceuticals do?
DelMar Pharmaceuticals was founded in 2010 and is headquartered in Vancouver, Canada. Operations center on the development of small molecule chemotherapies within the biotechnology sector. The lead candidate, VAL-083, targets refractory glioblastoma multiforme, with additional exploration for front-line glioblastoma and solid tumors such as non-small cell lung cancer and ovarian cancer. Focus remains on orphan cancer indications.
Who are the top competitors of DelMar Pharmaceuticals?
DelMar Pharmaceuticals's top competitors include Jazz Pharmaceuticals, Spark Therapeutics and BridgeBio.
How many acquisitions has DelMar Pharmaceuticals made?
DelMar Pharmaceuticals has made 1 acquisition, including Adgero Biopharma.
Who are DelMar Pharmaceuticals's investors?
DelMar Pharmaceuticals has 1 investor. Key investors include National Research Council Canada.